Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice
<p>Abstract</p> <p>Background</p> <p>Histone deacetylase (HDAC) inhibitors, developed as promising anti-tumor drugs, exhibit their anti-inflammatory properties due to their effects on reduction of inflammatory cytokines.</p> <p>Objective</p> <p>T...
Main Authors: | Wang Yun-Jie, Zhao Jin-Bo, Tian Feng, Yan Xiao-Long, Wang Jian, Ni Yun-Feng, Jiang Tao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-03-01
|
Series: | Respiratory Research |
Online Access: | http://respiratory-research.com/content/11/1/33 |
Similar Items
-
Attenuation of choroidal neovascularization by histone deacetylase inhibitor.
by: Nymph Chan, et al.
Published: (2015-01-01) -
Discovery of indole-3-butyric acid derivatives as potent histone deacetylase inhibitors
by: Yiming Chen, et al.
Published: (2021-01-01) -
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
by: Monica Phimmachanh, et al.
Published: (2020-10-01) -
Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020-08-01) -
Suberoylanilide Hydroxamic Acid, A Histone Deacetylase Inhibitor, Attenuates Postoperative Cognitive Dysfunction in Aging Mice
by: Min eJia, et al.
Published: (2015-09-01)